Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
- Status
- COMPLETED
- Phase
- PHASE3
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE4
Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan
- Status
- COMPLETED
- Phase
- N/A
To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
- Status
- COMPLETED
- Phase
- PHASE3
IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD
- Status
- COMPLETED
- Phase
- PHASE2
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
- Status
- COMPLETED
- Phase
- PHASE2
Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1